Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy

(2009) Yuriko Fujita et al.   JOURNAL OF IMMUNOTHERAPY

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

(2008) Catherine M. Bollard et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis

(2008) R. M. Brennan et al.   BLOOD

Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

(2008) Ellen Meijer et al.   CURRENT OPINION IN HEMATOLOGY

Rapid identification and sorting of viable virus-reactive CD4+ and CD8+ T cells based on antigen-triggered CD137 expression

(2008) Thomas C. Wehler et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation

(2008) Tobias Feuchtinger et al.   JOURNAL OF IMMUNOTHERAPY